Stryker unveils Synchfix EVT for flexible syndesmotic ankle fixation
The Synchfix EVT device builds on the previous Synchfix platform and introduces design improvements to minimise procedural complexity.
25 February 2026
25 February 2026
The Synchfix EVT device builds on the previous Synchfix platform and introduces design improvements to minimise procedural complexity.
VO659 aims to address nine polyglutamine disorders, including HD, SCA3 and SCA1.
The collaboration integrates Demeetra’s CleanCut CHO platforms and cell line services with NorthX Biologics’ GMP manufacturing expertise.
Of the 390 patients enrolled, 197 received seralutinib and 193 received placebo.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.